Tachyon Therapeutics

Tachyon Therapeutics, Inc. is developing novel, highly selective first-in-class compounds for the treatment of cancer. We are identifying and leveraging new approaches to address the core issues of cancer. By combining our expertise in molecular cancer biology, epigenetics, and cancer stem cell biology with preclinical and clinical drug development, we are creating new therapies to open up innovative pathways for treating advanced cancers.